520 related articles for article (PubMed ID: 32999202)
1. [Membrane Transporters and Their Regulatory Mechanisms at the Brain and Retinal Barriers to Establish Therapies for Refractory Central Nervous System Diseases].
Akanuma SI
Yakugaku Zasshi; 2020; 140(10):1235-1242. PubMed ID: 32999202
[TBL] [Abstract][Full Text] [Related]
2. Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
Zhang Z; Uchida Y; Hirano S; Ando D; Kubo Y; Auriola S; Akanuma SI; Hosoya KI; Urtti A; Terasaki T; Tachikawa M
Mol Pharm; 2017 Nov; 14(11):3729-3738. PubMed ID: 28954515
[TBL] [Abstract][Full Text] [Related]
3. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
Ohtsuki S
Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
[TBL] [Abstract][Full Text] [Related]
4. Inflammation-Induced Attenuation of Prostaglandin D
Akanuma SI; Hashimoto K; Yoshida Y; Kubo Y; Hosoya KI
Biol Pharm Bull; 2020; 43(11):1669-1677. PubMed ID: 33132311
[TBL] [Abstract][Full Text] [Related]
5. Excitatory Amino Acid Transporter 1-Mediated L-Glutamate Transport at the Inner Blood-Retinal Barrier: Possible Role in L-Glutamate Elimination from the Retina.
Sakurai T; Akanuma S; Usui T; Kubo Y; Tachikawa M; Hosoya K
Biol Pharm Bull; 2015; 38(7):1087-91. PubMed ID: 26133720
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers.
Tachikawa M; Hosoya K; Terasaki T
Adv Pharmacol; 2014; 71():337-60. PubMed ID: 25307222
[TBL] [Abstract][Full Text] [Related]
7. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
Tachikawa M; Uchida Y; Terasaki T
Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
[TBL] [Abstract][Full Text] [Related]
8. [Carrier-mediated Transport of Cationic Drugs across the Blood-Tissue Barrier].
Kubo Y
Yakugaku Zasshi; 2015; 135(10):1135-40. PubMed ID: 26423869
[TBL] [Abstract][Full Text] [Related]
9. Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; comparison of gene expression between the blood-brain and -retinal barriers.
Ohtsuki S; Tomi M; Hata T; Nagai Y; Hori S; Mori S; Hosoya K; Terasaki T
J Cell Physiol; 2005 Sep; 204(3):896-900. PubMed ID: 15795901
[TBL] [Abstract][Full Text] [Related]
10. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
Miyajima M; Kusuhara H; Fujishima M; Adachi Y; Sugiyama Y
Drug Metab Dispos; 2011 May; 39(5):814-9. PubMed ID: 21325432
[TBL] [Abstract][Full Text] [Related]
11. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier.
Chapy H; Saubaméa B; Tournier N; Bourasset F; Behar-Cohen F; Declèves X; Scherrmann JM; Cisternino S
Br J Pharmacol; 2016 Feb; 173(3):497-510. PubMed ID: 26507673
[TBL] [Abstract][Full Text] [Related]
13. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4).
Ose A; Ito M; Kusuhara H; Yamatsugu K; Kanai M; Shibasaki M; Hosokawa M; Schuetz JD; Sugiyama Y
Drug Metab Dispos; 2009 Feb; 37(2):315-21. PubMed ID: 19029202
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in drug and nutrient transport across the blood-retinal barrier.
Kubo Y; Akanuma SI; Hosoya KI
Expert Opin Drug Metab Toxicol; 2018 May; 14(5):513-531. PubMed ID: 29719158
[TBL] [Abstract][Full Text] [Related]
15. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system.
Ohtsuki S
Biol Pharm Bull; 2004 Oct; 27(10):1489-96. PubMed ID: 15467183
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of glutathione-conjugate efflux from the brain into blood: Involvement of multiple transporters in the course.
Okamura T; Okada M; Kikuchi T; Wakizaka H; Zhang MR
J Cereb Blood Flow Metab; 2020 Jan; 40(1):116-125. PubMed ID: 30346895
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier].
Ohtsuki S; Hori S; Terasaki T
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):55-64. PubMed ID: 12843573
[TBL] [Abstract][Full Text] [Related]
18. The impact of efflux transporters in the brain on the development of drugs for CNS disorders.
Taylor EM
Clin Pharmacokinet; 2002; 41(2):81-92. PubMed ID: 11888329
[TBL] [Abstract][Full Text] [Related]
19. Functional Characterization of Carrier-Mediated Transport of Pravastatin across the Blood-Retinal Barrier in Rats.
Fujii S; Setoguchi C; Kawazu K; Hosoya K
Drug Metab Dispos; 2015 Dec; 43(12):1956-9. PubMed ID: 26431714
[TBL] [Abstract][Full Text] [Related]
20. Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.
Li L; Agarwal S; Elmquist WF
Drug Metab Dispos; 2013 Mar; 41(3):659-67. PubMed ID: 23297298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
